Cannapharmarx (CPMD) has released an update.
CannaPharmaRx has secured the coveted IMC-GAP and GACP certifications, essential for selling cannabis in Israel, a market leader in medical cannabis. These international certifications underscore the company’s commitment to high-quality, safe, and environmentally sound cannabis production. CEO Dean Medwid highlights these milestones as key to the company’s global expansion and imminent product delivery to the Israeli market.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
